Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Diagnostics Pipeline: Testing for Intestinal Parasites Takes Step Forward
The EasyScreen assay received 510(k) clearance from the Food and Drug Administration earlier this year–but with a catch
AI in Genomics: The Next Generation
How artificial intelligence and machine learning tools stand to benefit clinical labs throughout the genomics pathway.
HIV Screening Underutilized, Particularly in Physicians’ Offices
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Refined PSA Screening Strategies May Catch More Aggressive Cases
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Autopsy Becoming Viable to Implement
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Genomic Data Changing Design of Oncology Clinical Trials
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Sorting Cell-Free DNA by Length May Increase Tumor Detection
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Embryo Mitochondrial DNA Levels May Aid IVF Selection
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Diabetes Screening in ER Improves Detection in High Prevalence Areas
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Incidental Pharmacogenomic Findings Can Help Personalize Treatment
From - Diagnostic Testing & Emerging Technologies
Clinically relevant pharmacogenomic findings are seen in single nucleotide polymorphism (SNP) genotyping and exome sequencing data…
Reference Pricing Cuts Prices for Lab Tests by One-Third
From - Diagnostic Testing & Emerging Technologies
Reference pricing is associated with nearly a one-third reduction in the average price paid for 285 different types of tests, according to a…
Corporate Venture Capital Ups Investments in Health Deals
From - Diagnostic Testing & Emerging Technologies
Health care corporate venture capital (CVC) is increasing across all sectors of the industry in terms of number of deals, dollars invested, and number of…
